CCF0058981
CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CLpro (SC2) inhibitor with an IC50 of 68 nM. CCF0058981 inhibits SC1 (SARS-CoV-1 3CLpro) with an IC50 of 19 nM. CCF0058981 has antiviral efficacy and has the potential for COVID-19 research[1].
Product Specifications
CAS Number
2708934-53-4
Product Name Alternative
CCF981
UNSPSC
12352005
Hazard Statement
H315, H319
Target
SARS-CoV; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ccf0058981.html
Purity
98.02
Solubility
DMSO : 25 mg/mL (ultrasonic; adjust pH to 2 with HCl)
Smiles
O=C(N(C1=CC=C(C2=CNC=N2)C=C1)CC3=CC=CC(Cl)=C3)CN4N=NC5=CC=CC=C54
Molecular Formula
C24H19ClN6O
Molecular Weight
442.90
Precautions
H315, H319
References & Citations
[1]Sang Hoon Han, et al. Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL pro) . J Med Chem. 2021 Aug 4; acs.jmedchem.1c00598.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP22383PU-N 100 µg
Cytochrome P450 2E1 (CYP2E1) Goat Polyclonal Antibody
Sign In for Pricing
View Details 
